March 5, 2018
Artios, Masaryk in in-licensing deal for DNA nucleases targeting drug development
Artios Pharma has exercised its option to in-license the first nuclease drug development with Masaryk University in the Czech Republic,…
Pharmaceuticals, Biotechnology and Life Sciences
Artios Pharma has exercised its option to in-license the first nuclease drug development with Masaryk University in the Czech Republic,…
Artios Pharma has named US-based MBA, CA, CPA Pierre Legault as Chairman of its Board of Directors, to be effective immediately. Citing…